Journal
NATURE
Volume 439, Issue 7072, Pages 95-99Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nature04323
Keywords
-
Categories
Funding
- NCI NIH HHS [R01 CA107263] Funding Source: Medline
Ask authors/readers for more resources
Neuroblastoma, the most common paediatric solid tumour, arises from defective neural crest cells(1). Genetic alterations occur frequently in the most aggressive neuroblastomas(1). In particular, deletion or suppression of the proapoptotic enzyme caspase-8 is common in malignant, disseminated disease, although the effect of this loss on disease progression is unclear(2-4). Here we show that suppression of caspase-8 expression occurs during the establishment of neuroblastoma metastases in vivo, and that reconstitution of caspase-8 expression in deficient neuroblastoma cells suppressed their metastases. Caspase-8 status was not a predictor of primary tumour growth; rather, caspase-8 selectively potentiated apoptosis in neuroblastoma cells invading the collagenous stroma at the tumour margin. Apoptosis was initiated by unligated integrins by means of a process known as integrin-mediated death(5). Loss of caspase-8 or integrin rendered these cells refractory to integrin-mediated death, allowed cellular survival in the stromal microenvironment, and promoted metastases. These findings define caspase-8 as a metastasis suppressor gene that, together with integrins, regulates the survival and invasive capacity of neuroblastoma cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available